F-group (family)
5001.1.1.7 Frizzled
Ligands and drugs
152
Member domains
30
with ligand contacts (≤ 4 Å)
19.7% of members
25
with DrugDomain annotations
16.4% of members
15
with a DrugBank compound
9.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5001.1.1.7 belongs to X-group 5001 Family A G protein-coupled receptor-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 8 |
| DB00141 | NAG | N-Acetylglucosamine | 5 |
| DB03831 | MPG | [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate | 3 |
| DB08828 | VIS | Vismodegib | 2 |
| DB12550 | 1KS | Taladegib | 2 |
| DB01047 | — | — | 1 |
| DB06786 | — | — | 1 |
| DB09143 | — | — | 1 |
| DB11978 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 8 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 6 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 5 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 5 |
| 836 | N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide | 4 |
| MPG | [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate | 3 |
| OLA | OLEIC ACID | 3 |
| V0S | 3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-{[3-(pyridin-4-yl)phenyl]methyl}-1-benzothiophene-2-carboxamide | 3 |
| 1KS | 4-fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide | 2 |
| CO1 | 17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL | 2 |
| CY8 | Cyclopamine | 2 |
| NAmetal | SODIUM ION | 2 |
| PLM | PALMITIC ACID | 2 |
| VIS | 2-chloranyl-~{N}-(4-chloranyl-3-pyridin-2-yl-phenyl)-4-methylsulfonyl-benzamide | 2 |
| A1JGQ | ethyl 3-[2-[(2-fluorophenyl)amino]-2-oxidanylidene-ethyl]-5-methyl-4-oxidanylidene-thieno[2,3-d]pyrimidine-6-carboxylate | 1 |
| A8T | 2-{6-[4-(4-benzylphthalazin-1-yl)piperazin-1-yl]pyridin-3-yl}propan-2-ol | 1 |
| LKD | 3-chloro-4,7-difluoro-N-{[2-methoxy-5-(pyridin-4-yl)phenyl]methyl}-N-[trans-4-(methylamino)cyclohexyl]-1-benzothiophene-2-carboxamide | 1 |
| OLB | (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 1 |
| SG8 | 3-chloro-4,7-difluoro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide | 1 |
| SNT | (E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methanimine | 1 |